Cargando…

Anti-PD-1 Therapy-Associated Perforating Colitis

Inhibition of immune checkpoint T cell regulatory molecules by using programmed cell death protein 1 (PD-1), or its ligand (PDL-1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) has been increasingly used to treat advanced malignancies. The immune-related adverse effects associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celli, Romulo, Kluger, Harriet M., Zhang, Xuchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000840/ https://www.ncbi.nlm.nih.gov/pubmed/29955400 http://dx.doi.org/10.1155/2018/3406437

Ejemplares similares

Pathology of Alcoholic Liver Disease
por: Celli, Romulo, et al.
Publicado: (2014)

Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report
por: d’Apolito, Maria, et al.
Publicado: (2022)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

A case of spontaneous colonic perforation in collagenous colitis
por: Mori, Haruki, et al.
Publicado: (2019)

B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
por: Damsky, William, et al.
Publicado: (2019)

Perforation in a patient with stercoral colitis and diverticulosis: who did it?
por: Bhatt, Vijaya R., et al.
Publicado: (2014)

Obstructive Colitis with Minor Perforation Induced by Double Sigmoid Adenocarcinoma
por: Morita, Toshihiro, et al.
Publicado: (2020)

Colon perforation due to collagenous colitis: A case report
por: Ito, Kei, et al.
Publicado: (2023)

Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment
por: Paolini, Léa, et al.
Publicado: (2018)

Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
por: Afzal, Muhammad Zubair, et al.
Publicado: (2018)

Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
por: Ikeda, Sadakatsu, et al.
Publicado: (2016)

Wong-type dermatomyositis during anti–PD-1 therapy
por: Yu, Wesley Y., et al.
Publicado: (2018)

Histologic patterns of liver injury induced by anti-PD-1 therapy
por: Zhang, Dongwei, et al.
Publicado: (2019)

Transstomal Small Bowel Evisceration after Colonic Perforation Secondary to Ischemic Colitis
por: Guner, Ali, et al.
Publicado: (2012)

A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively
por: Delasos, Lukas, et al.
Publicado: (2019)

Anti-PD-1, anti-VEGF, and temozolomide therapy in a patient with recurrent glioblastoma: a case report
por: Chen, Can, et al.
Publicado: (2020)

Infectious Colitis Associated With Ipilimumab Therapy
por: McCutcheon, Jessica L., et al.
Publicado: (2014)

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma
por: Tran, Thuy T., et al.
Publicado: (2023)

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
por: Sindhu, Simran, et al.
Publicado: (2017)

Necrotizing Colitis with Perforation Proximal to Obstructive Ascending Colon Cancer: A Case Report
por: Satyam, Satyam, et al.
Publicado: (2022)

Sigmoid colon perforation with splenic abscess due to ulcerative colitis: A case report and review of the literature
por: Zheng, Longkun, et al.
Publicado: (2023)

Anti-PD-1-Induced Hidradenitis Suppurativa
por: Maillard, Alexia, et al.
Publicado: (2021)

Non-perforated Stercoral Colitis patients with septic shock have a higher mortality than their perforated counterparts. A case report and review of literature
por: Reategui, Cesar, et al.
Publicado: (2022)

Collagenous colitis presenting as spontaneous perforation in an 80 year old woman: Report of a Case
por: Mitchell, Andrew, et al.
Publicado: (2016)

A case of colonic perforation in collagenous colitis without diarrheal symptoms.: A case report
por: Sugiyama, Tomohiro, et al.
Publicado: (2023)

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder
por: Wang, Xiaoxiao, et al.
Publicado: (2021)

Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma
por: Vyas, Monika, et al.
Publicado: (2019)

Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma
por: Smithy, James W., et al.
Publicado: (2017)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
por: Miller, Natalie J., et al.
Publicado: (2018)

Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: Histopathologic Features and Clinical Correlations
por: Ta, Robert, et al.
Publicado: (2017)

Endoscopic and histopathologic features of Anti‐PD‐1‐related collagenous colitis
por: Kikuchi, Hidezumi, et al.
Publicado: (2022)

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
por: Djureinovic, Dijana, et al.
Publicado: (2023)

A rare case report of recurrent atypical meningioma with multiple metastases treated with anti-PD-1 and anti-VEGF therapy
por: Zhao, Jia-Li, et al.
Publicado: (2022)

Minimal change disease associated with anti-PD1 immunotherapy: a case report
por: Gao, Bixia, et al.
Publicado: (2018)

Nasal Septal Perforation in Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Ishii, Yusho, et al.
Publicado: (2018)

Perforating Colitis Secondary to Immune Checkpoint Inhibitor Use in a Patient With Pericolonic Involvement by Rosai-Dorfman Disease
por: Bakhshwin, Ahmed, et al.
Publicado: (2022)

The significance of PD-1/PD-L1 imbalance in ulcerative colitis
por: Shi, Wei, et al.
Publicado: (2023)

T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary
por: Schmidt, Lindsay A., et al.
Publicado: (2009)

Immune-Related Pancytopenia Induced by Anti-PD-1 Therapy – Interrupt or Continue Treatment – The Role of Immunohistochemical Examination
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis
por: Seo, Hyun Il, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qugohs8ofak9r5c352u0m5ddjd